RT Journal Article
SR Electronic
T1 The clinical role of platelet glycoprotein Ilb/IIIa receptor inhibitors in ischemic heart disease
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 181
OP 189
VO 63
IS 3
A2 Vidt, Donald G.
A1 Lefkovits, Jeffrey
A1 Topol, Eric J.
YR 1996
UL http://www.ccjm.org/content/63/3/181.abstract
AB SUMMARY The platelet glycoprotein (GP) Ilb/IIIa receptor antagonists are powerful new antiplatelet drugs that show promise in reducing complications of coronary angioplasty and acute coronary syndromes.